Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

DUPILUMAB
(Dupixent (TN))

[1] Dupilumab (Dupixent)

[1] Dupilumab (Dupixent (TN)) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[5] 51, 97, 98, 160, 162 💬

2

Dupilumab (blinded)
(Dupixent (TN))

[1] Dupilumab (Dupixent)

[1] Dupilumab (Dupixent (TN)) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 98 💬

3

Dupilumab (open-label)
(Dupixent (TN))

[1] Dupilumab (Dupixent)

[1] Dupilumab (Dupixent (TN)) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 98 💬

4

Dupilumab 300Mg Solution for Injection
(Dupixent (TN))

[1] Dupilumab (Dupixent)

[1] Dupilumab (Dupixent (TN)) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 51 💬

5

Dupilumab Injection
(Dupixent (TN))

[1] Dupilumab (Dupixent)

[1] Dupilumab (Dupixent (TN)) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 160 💬

6

Dupilumab Prefilled Syringe
(Dupixent (TN))

[1] Dupilumab (Dupixent)

[1] Dupilumab (Dupixent (TN)) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[1] 160 💬

7

[1] Dupilumab (Dupixent)

[1] Dupilumab (Dupixent (TN)) 💬

[1] IL4R 💬

[8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬

[3] 98, 160, 162 💬